Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BCG VACCINE for Transitional cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 23 adverse event reports in the FDA FAERS database where BCG VACCINE was used for Transitional cell carcinoma.

Most Reported Side Effects for BCG VACCINE

Side Effect Reports % Deaths Hosp.
Disseminated bacillus calmette-guerin infection 87 20.8% 15 32
Immune reconstitution inflammatory syndrome 60 14.4% 5 13
Pyrexia 39 9.3% 5 18
Drug ineffective 35 8.4% 15 21
Off label use 35 8.4% 8 8
Granuloma 16 3.8% 1 5
Mycobacterial infection 16 3.8% 5 14
Vaccination complication 15 3.6% 0 5
Lymphadenopathy 14 3.4% 2 1
Disease progression 12 2.9% 2 0
Infection 12 2.9% 1 9
Neutropenia 12 2.9% 1 1
Skin lesion 12 2.9% 3 0
Acute kidney injury 11 2.6% 1 3
Bladder cancer 11 2.6% 0 2

Other Indications for BCG VACCINE

Bladder cancer (135) Immunisation (98) Bladder transitional cell carcinoma (49) Product used for unknown indication (30) Mantle cell lymphoma (9) Prophylaxis (9) Bladder neoplasm (7)

Other Drugs Used for Transitional cell carcinoma

PEMBROLIZUMAB (1,951) ENFORTUMAB VEDOTIN-EJFV (1,179) GEMCITABINE (825) ATEZOLIZUMAB (788) CISPLATIN (672) ENFORTUMAB VEDOTIN (649) NIVOLUMAB (595) AVELUMAB (554) CARBOPLATIN (493) GEMCITABINE\GEMCITABINE (255)

Related Pages

BCG VACCINE Full Profile All Transitional cell carcinoma Drugs BCG VACCINE Demographics BCG VACCINE Timeline